GB Patent

GB9121456D0 — Triazole antifungal agents

Assigned to Pfizer Ltd Great Britain · Expires 1991-11-27 · 34y expired

What this patent protects

PCT No. PCT/EP92/02278 Sec. 371 Date Apr. 8, 1994 Sec. 102(e) Date Apr. 8, 1994 PCT Filed Oct. 1, 1992 PCT Pub. No. WO93/07139 PCT Pub. Date Apr. 15, 1993The invention provides antifungal compounds of the formula: <IMAGE> (I) and the pharmaceutically acceptable salts t…

USPTO Abstract

PCT No. PCT/EP92/02278 Sec. 371 Date Apr. 8, 1994 Sec. 102(e) Date Apr. 8, 1994 PCT Filed Oct. 1, 1992 PCT Pub. No. WO93/07139 PCT Pub. Date Apr. 15, 1993The invention provides antifungal compounds of the formula: <IMAGE> (I) and the pharmaceutically acceptable salts thereof, wherein R is phenyl substituted by up to 3 substituents each independently selected from halo and trifluoromethyl; R1 is C1-C4 alkyl; R2 is <IMAGE> <IMAGE> R3 is -S(O)mR4; R4 is C1-C4 alkyl; and m is 0, 1 or 2, together with pharmaceutical compositions containing, and processes and intermediates for preparing, said compounds.

Drugs covered by this patent

Patent Metadata

Patent number
GB9121456D0
Jurisdiction
GB
Classification
—
Expires
1991-11-27
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Ltd Great Britain
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.